Enzymatic Ursodeoxycholic Acid Synthesis with Stepwise Cofactor Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing enantioselective processes for preparing ursodeoxycholic acid face challenges such as cofactor incompatibility, enzyme instability, reversibility of reactions, and overall process complexity, limiting scalability and enantiomeric purity.
Innovation Solution
An improved enantioselective enzymatic process involving multiple enzymatic steps with tailored cofactor use and pH, temperature, and solvent conditions to achieve high-yielding and enantiomerically pure ursodeoxycholic acid, including specific enzymes like IEP OX243, IER OX152, and IEP OX235, with careful control of reaction parameters.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If a one-pot multienzyme cascade is used to improve conversion efficiency, then productivity increases, but device complexity and difficulty of detecting and measuring increase due to multiple enzymes with different cofactor specificities
Solution Approach 1:
The patent extracts and separates the multienzyme cascade into individual enzymatic steps performed in separate reaction vessels. Each enzyme or enzyme combination is isolated and optimized independently, eliminating the complexity of managing multiple enzymes with different cofactor requirements in a single pot while maintaining overall conversion efficiency through sequential processing.
Solution Approach 2:
The synthesis pathway is segmented into distinct reaction stages, each optimized for specific enzymatic transformations. This segmentation allows independent optimization of reaction conditions, pH, temperature, and cofactor supply for each step, reducing the overall system complexity while preserving productivity.
2Manufacturing precision
If enzymes with mismatched cofactor requirements are used to achieve enzymatic transformation, then manufacturing precision improves, but device complexity increases due to cofactor regeneration challenges
Solution Approach 1:
The patent applies local quality by providing specific cofactor regeneration systems tailored to each enzymatic step's requirements. Each reaction vessel contains the appropriate cofactor regeneration machinery needed for that specific enzyme, rather than attempting a universal system. This localized approach maintains high enantioselectivity while reducing overall system complexity.
Solution Approach 2:
The patent introduces intermediary cofactor carriers that facilitate electron transfer between enzymatic steps with different cofactor requirements. These intermediary systems act as mediators that bridge the cofactor specificity gaps between different enzymes, enabling precise stereoselective transformations without requiring complex direct regeneration systems for each enzyme.
3Manufacturing precision
If dehydrogenase-catalyzed reactions are used to achieve selective transformations, then manufacturing precision improves, but reliability decreases due to reaction reversibility
Solution Approach 1:
The patent applies preliminary action by carefully controlling reaction conditions and substrate concentrations before the dehydrogenase reactions begin. By pre-optimizing pH, temperature, and substrate-to-enzyme ratios, the reactions are driven toward desired stereoselective products while minimizing reversibility issues. This preventive approach ensures reliable forward reactions with high stereoselectivity.
Solution Approach 2:
The patent employs parameter changes by adjusting reaction conditions such as pH, temperature, and substrate concentration to favor product formation and suppress reverse reactions. By dynamically optimizing these parameters during the reaction process, the system maintains high stereoselectivity while improving reliability through equilibrium control.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The process achieves high-yielding and enantiomerically pure ursodeoxycholic acid with purity exceeding 99.75% and minimal impurities, overcoming previous limitations of cofactor incompatibility and enzyme instability, enabling scalable production.
Implementation Method 1
enantioselective oxidation of cholic acid (3α, 7α, 12α-trihydroxy-5β-cholanic acid) to produce a compound of formula (III)... enantioselective oxidation of the compound of formula (IV) to produce a compound of formula (V)
Implementation Method 2
enantioselective reduction of 12-ketocholic acid (12-oxocholic acid) to produce ursodeoxycholic acid... enantioselective reduction of compound of formula (V) to produce ursodeoxycholic acid
Data Source
Figure 1~2
AI summary
Improved enantioselective enzymatic processes for preparing ursodeoxycholic acid with high pharmaceutical purity are provided. Also provided are improved enantioselective enzymatic processes for preparing ursodeoxycholic acid with high yield and high pharmaceutical and enantiomeric purity.